742 Chapter 20
Formation of the Placenta and Amniotic Sac
As the blastocyst implants in the endometrium and the cho-
rion develops, the cells of the endometrium also undergo
changes. These changes, including cellular growth and the
accumulation of glycogen, are collectively called the decidual
reaction. This is because the maternal tissue in contact with
the chorion frondosum is called the decidua basalis. These
two structures—chorion frondosum (fetal tissue) and decidua
basalis (maternal tissue)—together form the functional unit
known as the placenta. The human placenta (Latin 5 cake) is
in the shape of a single disc.
Cells of the cytotrophoblast (see figs. 20.43 b and 20.45 a )
from the chorionic villi invade the spiral arteries of the endo-
metrium. As a result, by the end of the second trimester, the
spiral arteries have been remodeled into dilated tubes lined by
the cytotrophoblast. These produce a low vascular resistance,
so that more maternal blood flows into the placenta.
The disc-shaped human placenta is continuous at its outer
surface with the smooth part of the chorion, which bulges into
the uterine cavity. Immediately beneath the chorionic mem-
brane is the amnion, which has grown to envelop the entire
embryo ( fig. 20.46 ). The embryo, together with its umbilical
cord, is therefore located within the fluid-filled amniotic sac.
Amniotic fluid is formed initially as an isotonic secretion.
Later, the volume is increased and the concentration changed
by urine from the fetus. Amniotic fluid also contains cells that
Figure 20.46 The amniotic sac and placenta. Blood
from the embryo is carried to and from the chorion frondosum
by umbilical arteries and veins. The maternal tissue between
the chorionic villi is known as the decidua basalis; this tissue,
together with the chorionic villi, forms the functioning placenta.
The space between chorion and amnion is obliterated, and the
fetus lies within the fluid-filled amniotic sac.
Decidua
basalis
Chorion
frondosum
Placenta
Amniotic sac
containing
amniotic fluid
Chorion
Amnion
Umbilical
cord
CLINICAL APPLICATION
Amniocentesis ( fig. 20.47 ) entails aspiration of a small
amount of fluid containing fetal cells from the amniotic sac.
This procedure is usually performed when a woman is about
14 to 20 weeks pregnant and the fetus is at risk of genetic
abnormalities. Samples obtained by amniocentesis can be
analyzed by microscopic observation of the chromosomes
(a technique called karyotyping ), and by biochemical analy-
sis of DNA using a technology called chromosomal micro-
arrays. These techniques allow the detection of abnormal
numbers of chromosomes, as in Down’s syndrome ( trisomy
21 ) and Turner’s syndrome (with a single X). Additionally,
certain genetic disorders may be detected, including sickle-
cell disease, Tay-Sachs disease, cystic fibrosis, and mus-
cular dystrophy. Chorionic villus sampling ( CVS ), which
provides larger numbers of fetal cells than amniocentesis,
can be performed as early as 10 to 12 weeks of pregnancy.
A mother’s blood plasma contains a mixture of her DNA
and the DNA of the fetus, because some placental cells
undergo apoptosis and release their DNA into the blood.
Because of this, DNA analysis of the mother’s blood can
now be used to noninvasively test for the fetal sex (looking
for DNA, including the SRY, from the Y chromosome; sec-
tion 20.1). Scientists have even recently reported their abil-
ity to determine much of the genome of a fetus using DNA
in maternal plasma.
are sloughed off from the fetus, placenta, and amniotic sac.
Because all of these cells are derived from the same fertilized
ovum, all have the same genetic composition.
Amniocentesis is usually performed at about the sixteenth
week of pregnancy. By this time the amniotic sac contains
between 175 to 225 ml of fluid. Genetic diseases such as Down
syndrome (characterized by three instead of two chromosomes
number 21) can be detected by examining chromosomes;
diseases such as Tay-Sachs disease, in which degeneration of
myelin sheaths results from a defective enzyme, can be detected
by biochemical techniques.
Major structural abnormalities that may not be predict-
able from genetic analysis can often be detected by ultrasound.
Sound-wave vibrations are reflected from the interface of tissues
with different densities—such as the interface between the fetus
and amniotic fluid—and used to produce an image. This tech-
nique is so sensitive that it can be used to detect a fetal heartbeat
several weeks before it can be heard using a stethoscope.
Exchange of Molecules
Across the Placenta
The umbilical arteries deliver fetal blood to vessels within the
villi of the chorion frondosum of the placenta. This blood cir-
culates within the villi and returns to the fetus via the umbili-
cal vein. Maternal blood is delivered to and drained from the